Expression, purification and crystallization of CTB-MPR, a candidate mucosal vaccine component against HIV-1.

MLA

Lee, Ho-Hsien, et al. “Expression, Purification and Crystallization of CTB-MPR, a Candidate Mucosal Vaccine Component against HIV-1.” IUCrJ, vol. 1, no. Pt 5, Aug. 2014, pp. 305–17. EBSCOhost, https://doi.org/10.1107/S2052252514014900.

APA

Lee, H.-H., Cherni, I., Yu, H., Fromme, R., Doran, J. D., Grotjohann, I., Mittman, M., Basu, S., Deb, A., Dörner, K., Aquila, A., Barty, A., Boutet, S., Chapman, H. N., Doak, R. B., Hunter, M. S., James, D., Kirian, R. A., Kupitz, C., … Mor, T. S. (2014). Expression, purification and crystallization of CTB-MPR, a candidate mucosal vaccine component against HIV-1. IUCrJ, 1(Pt 5), 305–317. https://doi.org/10.1107/S2052252514014900

Chicago

Lee, Ho-Hsien, Irene Cherni, HongQi Yu, Raimund Fromme, Jeffrey D Doran, Ingo Grotjohann, Michele Mittman, et al. 2014. “Expression, Purification and Crystallization of CTB-MPR, a Candidate Mucosal Vaccine Component against HIV-1.” IUCrJ 1 (Pt 5): 305–17. doi:10.1107/S2052252514014900.